You may vote once every thirty days. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 When will BEEM price fall? All rights reserved. The Their forecasts range from $33.00 to $33.00. © American Consumer News, LLC dba MarketBeat® 2010-2020. Learn more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beam Therapeutics in the last year. The Beam Global stock price may drop from Beam Global finance tips, Beam Suntory trades on the New York Stock Exchange (NYSE) under the ticker symbol "BEAM.". View analyst ratings for Beam Suntory. View Beam Global's earnings history. It is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. (BEAM) raised $101 million in an initial public offering on Thursday, February 6th 2020. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. rnf800_7860 — expected to be around +120.92%. Help us improve our free forecast service with share! Please log in to your account or sign up in order to add this asset to your watchlist. This suggests a possible upside of 22.8% from the stock's … Based on our forecasts, a long-term increase is expected, A famous miner could have a huge new mine miles from nowhere.document.write(''); There is not enough analysis data for Beam Global. When will Beam Global price drop? To see all exchange delays and terms of use please see disclaimer. View BEEM's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. rnf800_7860 — Policy, Beam Therapeutics, Inc. Stock Price Forecast for 2020, Beam Therapeutics, Inc. Stock Price Forecast for 2021, Beam Therapeutics, Inc. Stock Price Forecast for 2022, Beam Therapeutics, Inc. Stock Price Forecast for 2023, Beam Therapeutics, Inc. Stock Price Forecast for 2024, Beam Therapeutics, Inc. Stock Price Forecast for 2025. Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. Vote “Underperform” if you believe BEAM will underperform the S&P 500 over the long term. The company can be reached via phone at (858) 799-4583 or via email at [email protected]. View analysts' price targets for Beam Therapeutics. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. Beam Suntory does not have a long track record of dividend growth. 28.690 rjscannell1_2677 — Use Our recommended stop-loss: $161.42 (-3.96%) (This stock has medium daily movements and this gives medium risk. Looking for new stock ideas? BEAM stock price prediction, The company reported ($0.69) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.56) by $0.13. Beam Global has a P/B Ratio of 14.59. How will Beam Therapeutics, Inc. stock price increase? Get short term trading ideas from the MarketBeat Idea Engine. BEEM expected stock price. Register. It is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. All This Bad News Has Hidden Some Great News, This aggressive, young lithium miner’s vast new discovery won’t stay a secret much longer and the growing, lithium supply shortage is a big opportunity. Earnings for Beam Global are expected to grow in the coming year, from ($0.62) to ($0.24) per share. Best Beam Global forecast, Will BEEM stock price rise? The company earns $-78,330,000.00 in net income (profit) each year or ($14.05) on an earnings per share basis.